Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrating Radiotherapy Into Chemotherapy With Pembrolizumab and Bevacizumab in Stage IVB Cervical Cancer
NCT06543576Phase 2Recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jul 2025
- Primary completion
- Jan 2031
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab, bevacizumab, Cisplatin micelle injection (HA132), Paclitaxel Micelles for Injection in Cervical Cancer (CC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jul 2025; status: recruiting.
02
Drugs
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT06543576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06543576.